1. Home
  2. AEVA vs MDXG Comparison

AEVA vs MDXG Comparison

Compare AEVA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEVA

Aeva Technologies Inc.

N/A

Current Price

$25.15

Market Cap

1.3B

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$3.68

Market Cap

530.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEVA
MDXG
Founded
2019
2006
Country
United States
United States
Employees
239
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
530.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
AEVA
MDXG
Price
$25.15
$3.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$26.50
$9.00
AVG Volume (30 Days)
2.3M
1.6M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
$85.37
N/A
Revenue Next Year
$132.72
$13.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.99
52 Week Low
$8.83
$3.03
52 Week High
$38.79
$7.99

Technical Indicators

Market Signals
Indicator
AEVA
MDXG
Relative Strength Index (RSI) 72.84 51.70
Support Level $12.37 $3.45
Resistance Level N/A $7.39
Average True Range (ATR) 2.51 0.12
MACD 0.70 0.03
Stochastic Oscillator 86.74 65.71

Price Performance

Historical Comparison
AEVA
MDXG

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: